AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2011
Mar 31, 2011
30826_dirs_2011-03-31_fb94321a-498c-4d2c-a400-3ad01e1fbbe9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2011-03-30
Reporting Person: WITT DANIEL P (Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-30 | Stock Option (Right to Buy) | $2.66 | D | 10000 | Disposed | 2011-04-03 | Common Stock (10000) | Direct |
Footnotes
F1: The option was cancelled by mutual agreement of the Rporting Person and the Issuer in advance of its scheduled expiration date. The Reporting Person received the difference between $3.70, the closing price of the ISsuer's Common Stock on the transaction date, and $2.66, the exercise price of the stock option, less any applicable withholding taxes.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23